louisiana semaglutide gastric stasis lawsuit Filed Against Ozempic, Mounjaro Over 'Stomach Paralysis' GLP-1 Gastroparesis Lawsuit: Stomach Paralysis

A 15-year retrospective study of over 1.6 million people with type 2 diabetes found no increased risk of postmenopausal breast cancer among GLP-1 users

Recent research found that 50% of Medicare beneficiaries would be interested in taking GLP-1 drugs for weight loss if they were covered by Medicare, so it is likely that many enrollees will be interested in tapping into the new GLP-1 Bridge program. Common Misunderstandings Dr

Subcutaneous administration of pegbelfermin over 16 weeks was generally well tolerated and significantly decreased hepatic fat fraction based on MRI in MASH subjects during a phase 2 study (NCT02413372)

This makes it tough to maintain fat loss, particularly around the mid-section